Bretylium Tosilate

溴苄铵托西酸盐

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameBretylium Tosilate
Drug Alias Namebretylii tosilas托西溴苄铵Bretylium Tosylate溴卡铵托西酸盐tosilato de bretilio +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockers
TargetsPotassium channel
Therapy Area/IndicationsArrhythmias, Cardiac
Global Approved IndicationsArrhythmias, Cardiac
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1986/04/16
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAmphastar
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsArrhythmias, Cardiac

Other Information

ATC CodeC01BD02
Related LinksWikipediaDrugBankKEGG